156 related articles for article (PubMed ID: 18796458)
21. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
22. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
23. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism.
Le Gal G; Righini M; Roy PM; Sanchez O; Aujesky D; Perrier A; Bounameaux H
Arch Intern Med; 2006 Jan; 166(2):176-80. PubMed ID: 16432085
[TBL] [Abstract][Full Text] [Related]
24. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
25. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant activity in patients with sickle cell trait.
Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
[TBL] [Abstract][Full Text] [Related]
27. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism.
Demers C; Ginsberg JS; Johnston M; Brill-Edwards P; Panju A
Thromb Haemost; 1992 Apr; 67(4):408-12. PubMed ID: 1631787
[TBL] [Abstract][Full Text] [Related]
28. The VIDAS D-dimer test for venous thromboembolism: a prospective surveillance study shows maintenance of sensitivity and specificity when used in normal clinical practice.
Mountain D; Jacobs I; Haig A
Am J Emerg Med; 2007 May; 25(4):464-71. PubMed ID: 17499668
[TBL] [Abstract][Full Text] [Related]
29. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
30. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
[TBL] [Abstract][Full Text] [Related]
31. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
32. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies.
Aleil B; Meyer N; Wolff V; Kientz D; Wiesel ML; Gachet C; Cazenave JP; Lanza F
Thromb Haemost; 2006 Oct; 96(4):505-11. PubMed ID: 17003930
[TBL] [Abstract][Full Text] [Related]
33. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis.
Boneu B; Bes G; Pelzer H; Sié P; Boccalon H
Thromb Haemost; 1991 Jan; 65(1):28-31. PubMed ID: 2024237
[TBL] [Abstract][Full Text] [Related]
34. Laboratory markers in the diagnosis of venous thromboembolism.
Caprini JA; Glase CJ; Anderson CB; Hathaway K
Circulation; 2004 Mar; 109(12 Suppl 1):I4-8. PubMed ID: 15051662
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
[TBL] [Abstract][Full Text] [Related]
36. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
37. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
[TBL] [Abstract][Full Text] [Related]
38. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
[TBL] [Abstract][Full Text] [Related]
39. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
Dati F; Pelzer H; Wagner C
Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
[TBL] [Abstract][Full Text] [Related]
40. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
